Colin Shannon is President, Chief Executive Officer (CEO) and Director of PRA. Since 2007, Mr. Shannon has served as President and Chief Operating Officer (COO) for PRA. Mr. Shannon has contributed significantly to the development of PRA's current mission and vision. As COO, he has been instrumental in driving PRA's decision-making processes and building a talented pool of clinical professionals. Prior to joining PRA, Mr. Shannon was Executive Vice President of Global Clinical Operations at Pharmaceutical Product Development, Inc. (PPD) where he oversaw clinical, biostatistics and data management operations worldwide. During his 12 year association with PPD, he held various leadership roles including COO for the company’s European division and Chief Financial and Administration Officer for Europe and the Pacific Rim. Prior to PPD, Mr. Shannon had more than 15 years of experience in a variety of financial and accounting positions in the utility and multimedia industries. Mr. Shannon earned his MBA from London's City University and is board certified by the Chartered Association of Certified Accountants.

his research is based on clinical health